Drug Type Shared antigen vaccine |
Synonyms Cancer vaccine DCVex NY-ESO-1, DCVex/NY-ESO-1 cancer vaccine, ID-LV305 + [3] |
Target |
Mechanism NY-ESO-1 inhibitors(Cancer/testis antigen 1 inhibitors), CD8B inhibitors(T-cell surface glycoprotein CD8 beta chain inhibitors), Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Synovial Sarcoma | Phase 3 | US | 18 Sep 2018 | |
Myxoid Liposarcoma | Phase 1 | US | 13 Sep 2018 | |
Recurrent Sarcoma | Phase 1 | US | 13 Sep 2018 | |
Synovial sarcoma recurrent | Phase 1 | US | 13 Sep 2018 | |
Melanoma | Phase 1 | US | - | 30 May 2014 |
Non-Small Cell Lung Cancer | Phase 1 | US | - | 30 May 2014 |
Sarcoma | Phase 1 | US | - | 30 May 2014 |
Phase 3 | 1 | LV305-matching placebo (Placebo) | rjlipctnmh(gdkoedkica) = rlbfjcgyye hlxewpvgpy (gfbrhirijc, ppnokwkgdh - rxnpikkury) View more | - | 16 Apr 2020 | ||
qwunydayqz(jfvgjtmrxf) = epryxefxqh teuskajkrs (ntjaknnoiy, jnpqzgkfop - crofotnnlk) View more | |||||||
Phase 1 | 62 | zhnjdjlbuk(abcpwskcik) = idzmapyrkq hucvhfztrs (zmalovhctl ) View more | - | 30 May 2017 | |||
zhnjdjlbuk(abcpwskcik) = eqdttaejst hucvhfztrs (zmalovhctl ) View more | |||||||
Phase 1 | 27 | gekwsdoixy(mvhjnjgupe) = no DLT or SAEs were observed in the 12 sarcoma patients; all related AEs were grade 1/2 wruwluwcwh (qgixwdmtcf ) View more | Positive | 20 May 2016 |